Recombinant anti-human ErbB2/HER2 Antibody (Trastuzumab)

Product code: 10-2002

Clonality : Monoclonal
Application : Functional Assay, FACS
Reactivity : Human

Shipping Info:

2000 (throughout India)
Order now and get it on next 3-4 working days* (Major Cities)

100 μg

Available Pack Size(s)


Bulk Order

Shipping Info:

2000 (throughout India)

Order now and get it on next 3-4 working days* (Major Cities)

Gene : ERBB2
Gene ID : 2064
Uniprot ID : P04626
Alternative Name : ERBB2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, CD340; HER 2; HER2; NEU; herstatin; p185erbB2; proto-oncogene Neu; c-erb B2/neu protein; proto-oncogene c-ErbB-2.
Format : Purified
Amount : 100 μg
Clone name : ABM2A1G1

Target: ErbB2
Trade name: Samceptin,
Generic name: Trastuzumab
Product Origin: Recombinant in CHO cells
Product Construction: Immunoglobulin G1, anti-(human p185neu receptor) (human-mouse monoclonal rhuMab HER2 g1- chain), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimerThe drug Trastuzumab (Brand name Herceptin®, From Roche/Genentech) is a monoclonal antibody and works by targeting breast cancer cells that overexpress the HER2 protein. Overexpression (or amplification) of the HER2 protein is associated with accelerated cell division. By binding to the protein receptors on these cells, Trastuzumab interrupts the growth signal, thereby slowing the growth and spread of tumours. Approximately 20% of breast cancers overexpress the HER2 protein. Amplification of HER2 in breast cancer cells has been correlated with adverse prognostic factors such as large tumour size, high nuclear grade, and decreased expression of estrogen and progesterone hormone receptors. HER2 amplification has also been associated with reduced disease free survival, and overall survival, for women with node positive or node negative disease. Trastuzumab (anti-p185, rhuMab HER2), which is a humanised monoclonal antibody that binds to the HER2 protein. HER-2 is a transmembrane spanning receptor-like protein, which is structurally related to the epidermal growth factor receptor and has been shown to inhibit the proliferation of human tumor cells that overexpress HER2 both in vitro and in vivo.

The developed biosimilar to Herceptin, designated as Samceptin. The biochemical characterizations and the functional assays suggest that Samceptin is highly similar in structure and activity to Herceptin.

*Disclaimer: Herceptin® is a registered trade mark of Genentech, Inc.  Samceptin can only be used for research purposes. Not to be used as diagnostic for therapeutic purposes. 

Purification : Purity: >98.0% as determined by SEC-HPLC & SDS-PAGE.
Content : In Trehalose, Histidine, Histidine-Cl, Tween-20
Storage condition : Store the antibody at 4°C, stable for 6 months. For long-term storage, store at -20°C. Avoid repeated freeze and thaw cycles.
AA sequence : PepMap Analysis of N terminal amino acids sequence: H chain: EVQLVESGGGLVQPG, L chain: DIQMTQSPSSLSASV

The biological activities of Samcepetin was compared with commercially available innovator drug, Herceptin from Roche.
Recommended dilutions: FACS: 1-2 μg/10^6 cells, ADCC: 20-25 mg/ml. However, this need to be optimized based on the research applications.

Recombinant anti-human ErbB2/HER2 Antibody (Trastuzumab)

Product code: 10-2002

Can't read the image? click here to refresh.